Daily Stock Setups

ZYNEX Obtains Medicare Accreditation

Posted on: Mon, 05 Oct 2009 09:15:00 EDT

Symbols: ZYXI

Do you know when to trade ZYXI ?

Check for a PowerRating from TradingMarkets

LITTLETON, Colo., Oct 05, 2009 (BUSINESS WIRE) --
ZYXI | Quote | Chart | News | PowerRating -- Zynex, Inc. (OTCBB:ZYXI),
a provider of pain management systems and electrotherapy products for
medical patients with functional disability, announces it has obtained
accreditation as a Medicare DMEPOS (Durable Medical Equipment,
Prosthetics, Orthotics, and Supplies) supplier, as required to maintain
its status as provider to Medicare and several private health insurance
companies. The accreditation was performed by the Compliance Team, one
of ten organizations certified to audit and accredit durable medical
equipment providers in the US.

Thomas Sandgaard, CEO of Zynex explains: "It was very important to us to
obtain this accreditation before the September 30 deadline. Not only do
we maintain our status of being a provider to Medicare, but our
customers know that we have met the high standards and
procedures which are required for accreditation. Other providers that
are not able to comply with these standards will be excluded from being
a provider to Medicare and several private health insurance companies in
the future."

About Zynex

Zynex, Inc. (founded in 1996) engineers, manufactures, markets and sells
its own design of electrotherapy medical devices in two distinct
markets: standard digital electrotherapy products for pain relief and
pain management; and the NeuroMove(TM) for stroke and spinal
cord injury (SCI) rehabilitation. Zynex's product lines are fully
developed, FDA-cleared, commercially sold, an have been developed to
uphold the Company's mission of improving the quality of life for
patients suffering from impaired mobility due to stroke, spinal cord
injury, or debilitating and chronic pain.

Safe Harbor Statement

Certain statements in this release are "forward-looking" and as such are
subject to numerous risks and uncertainties. Actual results may vary
significantly from the results expressed or implied in such statements.
Factors that could cause actual results to materially differ from
forward-looking statements include, but are not limited to, the need to
obtain additional capital in order to grow our business, larger
competitors with greater financial resources, the need to keep pace with
technological changes, our dependence on the reimbursement from
insurance companies for products sold or rented to our customers,
acceptance of our products by health insurance providers, acceptance of
our products by hospitals and clinicians, our dependence on third party
manufacturers to produce our goods on time and to our specifications,
implementation of our sales strategy including a strong direct sales
force, the uncertain outcome of pending material litigation and other
risks described in our 10-K Report for the year ended December 31, 2008.

SOURCE: Zynex, Inc.


Zynex, Inc. 
Thomas Sandgaard, 303-703-4906 
CEO 
www.zynexmed.com

For full details on (ZYXI) ZYXI. (ZYXI) has Short Term PowerRatings at TradingMarkets. Details on (ZYXI) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.